Gland Pharma Limited Share Price and Company Fundamentals
Last traded: Last Friday at 10:00 AM
Gland Pharma Limited engages in manufacturing and sale of injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and internationally. It engages in research and development of pharmaceutical active pharmaceutical ingredient products, including synthesis of complex drug molecules, such as low molecular weight heparins, corticosteroids, peptides, and cytotoxic molecules. The company also offers its products for various therapeutic categories, such as anti- diabetic, anti-malarial, anti-infectives, anti-neoplastic, blood related, cardiac, gastro-intestinal, gynaecological, hormones, neuro/Cns, ophthal/otological, and other areas, as well as pain/analgesics, respiratory and pulmonology, and vitamins, minerals, and nutrients. In addition, it provides contract development, dossier compilation, technology transfer services. The company was incorporated in 1978 and is based in Hyderabad, India. Gland Pharma Limited operates as a subsidiary of Fosun Pharma Industrial Pte. Ltd.
Key Metrics
PE ratio
31.62
PB ratio
2.80
Dividend yield
1.11%
Beta
0.40
Market cap
₹267.75B
Enterprise value
₹239.00B
Company profile
| Industry / Sector | Drug Manufacturers - Specialty & Generic / Healthcare |
|---|---|
| Full time employees | 4351 |
| Website | https://www.glandpharma.com |
| Mailing address | Plot No. 11 & 84, TSIIC Phase: IV Pashamylaram (V) Patancheru (M) Sangareddy District Hyderabad 502307 India |
| Phone / Fax | 91 84 5569 9999 / |
Dividends
Dividend yield
1.11%
Dividend amount
₹18.00
Payout ratio
35.01%
5Y Avg. yield
-%
Gland Pharma Limited paid ₹18.00 dividend and the ex-dividend date was 14 Aug 2025.The dividend payout ratio is 35.01%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.GLAND dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Mar 2026, following are the company executives and directors listed on Gland Pharma Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Srinivas Sadu | Executive Chairman | 56 | |
| Mr. Shyamakant Giri | Chief Executive Officer | ||
| Mr. Ravi Shekhar Mitra | Chief Financial Officer | 48 | |
| Mr. Sampath Kumar Pallerlamudi | Company Secretary & Vice-President of Compliance & CSR | 44 | |
| Mr. Satnam Singh Loomba | Chief Operating Officer | 57 | |
| Mr. Shriniwas P. Dange | Head of Investor Relations | ||
| Mr. Surinder Koul | Head of Domestic Marketing | ||
| Mr. Wriddhee Maitra | Vice President of Human Resources | ||
| Mr. K Raghuramachandra Rao | Head of Quality | ||
| Mr. R.V.R. Prabhakara Sastry | Head of R&D |
Profitability and management effectiveness
Profit margin
13.86%
Operating margin
19.30%
Return on assets
-
Return on equity
-
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Gland Pharma Limited is 267.75B and its enterprise value is 239.00B. The enterprise value to revenue ratio of GLAND is 3.91. The enterprise value to EBITDA ratio of GLAND is 16.84.
The GLAND's stocks Beta value is 0.40 making it 60% less volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Gland Pharma Limited (NSE:GLAND) Frequently Asked Questions
1. What is Gland Pharma Limited's Stock Symbol?
Gland Pharma Limited trades on NSE under the ticker symbol "GLAND".
2. What is Gland Pharma Limited's stock price today?
One share of GLAND stock can currently be purchased for approximately ₹1625.1.
3. How can I contact Gland Pharma Limited?
Gland Pharma Limited's mailing address is Plot No. 11 & 84, TSIIC Phase: IV Pashamylaram (V) Patancheru (M) Sangareddy District Hyderabad 502307 India. The company can be reached via phone at 91 84 5569 9999.
4. What is Gland Pharma Limited's official website?
The official website of Gland Pharma Limited is https://www.glandpharma.com.